An Update on Gemcitabine-Based Chemosensitization Strategies in ...
Pancreatic ductal adenocarcinoma (PDAC) is characterized by abundant stroma, the main cellular constituents of which are cancer-associated fibroblasts (CAFs).
TITLE PAGE - ClinicalTrials.govIn a phase I study, the safety and efficacy of increasing doses of pamrevlumab were evaluated in combination with two chemotherapy agents, ... Pancreatic Cancer A ReviewHere we review the role of the individual growth factors in pancreatic cancer chemoresistance. Importantly, the interplay between the tumor ... 1. Etude CAPNO-PAUSE Étude de la variation de l ... - CHU de ReimsIn other PDAC pre-clinical studies pamrevlumab was shown to attenuate tumor growth, metastasis and angiogenesis[60]. These studies.
Autres Cours:
